Compare DVAX to:
After Hours: 1.30 0.00 (0.00%) 4:15pm ET
| Last Trade: | 1.30 |
|---|---|
| Trade Time: | 3:59pm ET |
| Change: | |
| Prev Close: | 1.29 |
| Open: | 1.30 |
| Bid: | 1.29 x 1000 |
| Ask: | 1.35 x 5000 |
| 1y Target Est: | 2.60 |
| Day's Range: | 1.30 - 1.34 |
|---|---|
| 52wk Range: | 0.22 - 3.35 |
| Volume: | 234,058 |
| Avg Vol (3m): | 1,208,740 |
| Market Cap: | 53.66M |
| P/E (ttm): | 18.57 |
| EPS (ttm): | 0.07 |
| Div & Yield: | N/A (N/A) |
| Thu, Nov 19 | DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online |
| Thu, Nov 19 | Dynavax Completes Enrollment of First Cohort of Patients in Phase 1b Clinical Trial for Hepatitis B TherapyMarketwire |
| Tue, Nov 17 | Big Pullback for Top Swine Flu Small-CapsIndie Research |
| Tue, Nov 10 | DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExEDGAR Online |
| Tue, Nov 10 | Dynavax Technologies to buy Symphony Dynamoat bizjournals.com |
| Tue, Nov 10 | Dynavax to buy Symphony Dynamoat MarketWatch |
| Tue, Nov 10 | Dynavax to Acquire Symphony Dynamo, Inc., Including $20 Million in Unrestricted CashMarketwire |
| Thu, Nov 5 | DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhEDGAR Online |
| Thu, Nov 5 | The $2000 Swine Flu DrugIndie Research |
| Thu, Nov 5 | Dynavax Appoints Francis R. Cano, Ph.D. to Board of DirectorsBusiness Wire |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.